Stephen Gunstream has served as a director and our President and Chief Executive Officer since May 2020 and served as our Chief Business Officer from December 2019 to May 2020. Stephen has more than 20 years of sales, marketing, research and development, and general management experience in the life sciences industry. From June 2015 to December 2019, Stephen served in multiple roles at Becton Dickinson & Co. (“BD”) (NYSE: BDX), a global medical technology company, most recently as Vice President and General Manager of BD Biosciences, where he was responsible for leading BD’s flow cytometry and genomics business. From 2008 to 2015, he served in multiple roles at Integrated DNA Technologies, Inc. (“IDT”), a leading supplier of custom nucleic acids, most recently as Chief Commercial Officer, where he was responsible for product development, global sales, and global marketing. Under Stephen’s leadership, IDT took advantage of its core DNA manufacturing strengths and launched several highly innovative products that re-positioned the company in the market, including the xGen® Exome Panel and gBlocks® Gene Fragments, the latter for which he was also named a co-inventor. Prior to IDT, from 2001 to 2008, Stephen held multiple product development and business development roles with Applied Biosystems, Inc. (now part of Thermo Fisher Scientific, Inc.), a biomedical technology company. Stephen received a bachelor’s degree in biomedical engineering from Northwestern University and an MBA from the Fuqua School of Business at Duke University. He is a named inventor on 10 issued patents and more than 25 pending patents.